A monoclonal antibody directed against human von Willebrand factor induces type 2B-like alterations

H. Ulrichts, J. Hársfalvi, L. Bene, J. Matkó, J. Vermylen, N. Ajzenberg, D. Baruch, Hans Deckmyn, I. Tornai

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

We have previously described a monoclonal antibody (mAb), 1C1E7, against von Willebrand factor (VWF), that increases ristocetin-induced platelet aggregation (RIPA) and induces a preferential binding of the high-molecular-weight multimers of VWF to platelet GPIb. Further investigations using a rotational viscometer at a shear rate of 4000 s-1 could now demonstrate that shear-induced platelet aggregation (SIPA) is significantly increased with 1C1E7 and that this could be completely inhibited by the anti-GPIb mAb 6D1. In contrast, platelet adhesion to a collagen surface at a shear rate of 2600 s-1, using a rectangular perfusion chamber, was significantly inhibited in the presence of 1C1E7. When citrated whole blood was incubated with 1C1E7, a spontaneous binding of VWF to the platelet GPIb could be demonstrated by flow cytometric analysis. Parallel to this, a decrease of the highest molecular weight multimers of VWF in the plasma was found. Platelets with bound VWF on their surface were able to form macroaggregates but were no longer able to adhere. These phenomena are very similar to the alterations described in von Willebrand's disease type 2B. The epitope of this mAb could be localized to the N-terminal part of the subunit; therefore a distant conformational change in the A1 domain of VWF is suggested.

Original languageEnglish
Pages (from-to)1622-1628
Number of pages7
JournalJournal of Thrombosis and Haemostasis
Volume2
Issue number9
DOIs
Publication statusPublished - Sep 2004

Fingerprint

von Willebrand Factor
Monoclonal Antibodies
Blood Platelets
Platelet Aggregation
Type 2 von Willebrand Disease
Molecular Weight
Ristocetin
Epitopes
Collagen
Perfusion

Keywords

  • A-domain
  • Shear stress
  • Von Willebrand's disease

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A monoclonal antibody directed against human von Willebrand factor induces type 2B-like alterations. / Ulrichts, H.; Hársfalvi, J.; Bene, L.; Matkó, J.; Vermylen, J.; Ajzenberg, N.; Baruch, D.; Deckmyn, Hans; Tornai, I.

In: Journal of Thrombosis and Haemostasis, Vol. 2, No. 9, 09.2004, p. 1622-1628.

Research output: Contribution to journalArticle

Ulrichts, H. ; Hársfalvi, J. ; Bene, L. ; Matkó, J. ; Vermylen, J. ; Ajzenberg, N. ; Baruch, D. ; Deckmyn, Hans ; Tornai, I. / A monoclonal antibody directed against human von Willebrand factor induces type 2B-like alterations. In: Journal of Thrombosis and Haemostasis. 2004 ; Vol. 2, No. 9. pp. 1622-1628.
@article{9c531d9a58dd46c88cde3022ad2fc23d,
title = "A monoclonal antibody directed against human von Willebrand factor induces type 2B-like alterations",
abstract = "We have previously described a monoclonal antibody (mAb), 1C1E7, against von Willebrand factor (VWF), that increases ristocetin-induced platelet aggregation (RIPA) and induces a preferential binding of the high-molecular-weight multimers of VWF to platelet GPIb. Further investigations using a rotational viscometer at a shear rate of 4000 s-1 could now demonstrate that shear-induced platelet aggregation (SIPA) is significantly increased with 1C1E7 and that this could be completely inhibited by the anti-GPIb mAb 6D1. In contrast, platelet adhesion to a collagen surface at a shear rate of 2600 s-1, using a rectangular perfusion chamber, was significantly inhibited in the presence of 1C1E7. When citrated whole blood was incubated with 1C1E7, a spontaneous binding of VWF to the platelet GPIb could be demonstrated by flow cytometric analysis. Parallel to this, a decrease of the highest molecular weight multimers of VWF in the plasma was found. Platelets with bound VWF on their surface were able to form macroaggregates but were no longer able to adhere. These phenomena are very similar to the alterations described in von Willebrand's disease type 2B. The epitope of this mAb could be localized to the N-terminal part of the subunit; therefore a distant conformational change in the A1 domain of VWF is suggested.",
keywords = "A-domain, Shear stress, Von Willebrand's disease",
author = "H. Ulrichts and J. H{\'a}rsfalvi and L. Bene and J. Matk{\'o} and J. Vermylen and N. Ajzenberg and D. Baruch and Hans Deckmyn and I. Tornai",
year = "2004",
month = "9",
doi = "10.1111/j.1538-7836.2004.00865.x",
language = "English",
volume = "2",
pages = "1622--1628",
journal = "Journal of Thrombosis and Haemostasis",
issn = "1538-7933",
publisher = "Wiley-Blackwell",
number = "9",

}

TY - JOUR

T1 - A monoclonal antibody directed against human von Willebrand factor induces type 2B-like alterations

AU - Ulrichts, H.

AU - Hársfalvi, J.

AU - Bene, L.

AU - Matkó, J.

AU - Vermylen, J.

AU - Ajzenberg, N.

AU - Baruch, D.

AU - Deckmyn, Hans

AU - Tornai, I.

PY - 2004/9

Y1 - 2004/9

N2 - We have previously described a monoclonal antibody (mAb), 1C1E7, against von Willebrand factor (VWF), that increases ristocetin-induced platelet aggregation (RIPA) and induces a preferential binding of the high-molecular-weight multimers of VWF to platelet GPIb. Further investigations using a rotational viscometer at a shear rate of 4000 s-1 could now demonstrate that shear-induced platelet aggregation (SIPA) is significantly increased with 1C1E7 and that this could be completely inhibited by the anti-GPIb mAb 6D1. In contrast, platelet adhesion to a collagen surface at a shear rate of 2600 s-1, using a rectangular perfusion chamber, was significantly inhibited in the presence of 1C1E7. When citrated whole blood was incubated with 1C1E7, a spontaneous binding of VWF to the platelet GPIb could be demonstrated by flow cytometric analysis. Parallel to this, a decrease of the highest molecular weight multimers of VWF in the plasma was found. Platelets with bound VWF on their surface were able to form macroaggregates but were no longer able to adhere. These phenomena are very similar to the alterations described in von Willebrand's disease type 2B. The epitope of this mAb could be localized to the N-terminal part of the subunit; therefore a distant conformational change in the A1 domain of VWF is suggested.

AB - We have previously described a monoclonal antibody (mAb), 1C1E7, against von Willebrand factor (VWF), that increases ristocetin-induced platelet aggregation (RIPA) and induces a preferential binding of the high-molecular-weight multimers of VWF to platelet GPIb. Further investigations using a rotational viscometer at a shear rate of 4000 s-1 could now demonstrate that shear-induced platelet aggregation (SIPA) is significantly increased with 1C1E7 and that this could be completely inhibited by the anti-GPIb mAb 6D1. In contrast, platelet adhesion to a collagen surface at a shear rate of 2600 s-1, using a rectangular perfusion chamber, was significantly inhibited in the presence of 1C1E7. When citrated whole blood was incubated with 1C1E7, a spontaneous binding of VWF to the platelet GPIb could be demonstrated by flow cytometric analysis. Parallel to this, a decrease of the highest molecular weight multimers of VWF in the plasma was found. Platelets with bound VWF on their surface were able to form macroaggregates but were no longer able to adhere. These phenomena are very similar to the alterations described in von Willebrand's disease type 2B. The epitope of this mAb could be localized to the N-terminal part of the subunit; therefore a distant conformational change in the A1 domain of VWF is suggested.

KW - A-domain

KW - Shear stress

KW - Von Willebrand's disease

UR - http://www.scopus.com/inward/record.url?scp=13244259181&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13244259181&partnerID=8YFLogxK

U2 - 10.1111/j.1538-7836.2004.00865.x

DO - 10.1111/j.1538-7836.2004.00865.x

M3 - Article

C2 - 15333040

AN - SCOPUS:13244259181

VL - 2

SP - 1622

EP - 1628

JO - Journal of Thrombosis and Haemostasis

JF - Journal of Thrombosis and Haemostasis

SN - 1538-7933

IS - 9

ER -